← Clinical Evidence

SRC-843bc60acb63 Fereshtehnejad SM 2019

Evidence source and scope

Fereshtehnejad SM, et al. Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study. Brain. 2019;142(7):2051–2067. DOI 10.1093/brain/awz111

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1093/brain/awz111

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Fereshtehnejad SM, et al. Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study. Brain. 2019;142(7):2051–2067. DOI 10.1093/brain/awz111

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — gait

GaitP111/P154:ROC comparesiRBDphenoconverterswithhealthycontrolsattime0andbackdated2/4/6years,notbaselineiRBDconvertersversusnonconverters. Boundaryinterpretationcorrect. Source locator: OriginalOUPPDFMethodsDiagnosticUtilityp2054(lines229-239),Table3p2062;https://academic.oup.com/brain/article-pdf/142/7/2051/28881208/awz111.pdf Limit: NewprimaryPDFinspectionreplacesdependenceonpriorAIchecknotes. ReportisrightnottopresentROCaspersonalPDconversionrisk.

Limitations: Only scoped comparisons, not whole-paper certification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide